NervGen Reports Second Quarter 2026 Financial Results And Provides Business Updates
NGEN•Company brief
- NervGen reports second quarter 2026 financial results and provides business updates
Related News
Nasdaq trade halt continues <SVA.O> reason not available at 09:40 AM
SVA•
International Land Alliance Q2 FY26 net loss widens to $3.96 million; revenue drops to $142,496
ILAL•
Rain Enhancement Technologies publishes investor deck on ground-based ionization precipitation enhancement technology
RAIN•
CareCredit survey shows Americans overlook chiropractic care in long-term wellness routines, Synchrony says
SYF•
NYSE Halt <AHTpF.N> Add Info LST $5.250000
AHT•